Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
Getting covid-19 for the first time slightly increased the risk of heart inflammation, blood clots and bleeding disorders among children, whereas being vaccinated against the virus was much safer and ...
At a margin of 40%, Palantir delivered $476 million net income (GAAP). Overall, the company now has $6.4 billion in cash and cash equivalents. More importantly for investors, Palantir raised its FY ...
Michael Burry’s sizable put options on PLTR suggest cautious skepticism, even as the stock’s memetic narrative fuels ...
REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company seeking to revolutionize precision oncology through biomarker innovation, today announced the publication of the study "HER2DX in older ...